480 related articles for article (PubMed ID: 18379253)
1. Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.
Casillas-Ramirez A; Amine-Zaouali M; Massip-Salcedo M; Padrissa-Altés S; Bintanel-Morcillo M; Ramalho F; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
Crit Care Med; 2008 Apr; 36(4):1256-66. PubMed ID: 18379253
[TBL] [Abstract][Full Text] [Related]
2. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
Ramalho FS; Alfany-Fernandez I; Casillas-Ramirez A; Massip-Salcedo M; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
J Pharmacol Exp Ther; 2009 Apr; 329(1):130-40. PubMed ID: 19116369
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation.
Padrissa-Altés S; Franco-Gou R; Boillot O; Serafín A; Rimola A; Arroyo V; Rodés J; Peralta C; Roselló-Catafau J
Liver Transpl; 2009 Mar; 15(3):313-20. PubMed ID: 19242996
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion.
Massip-Salcedo M; Zaouali MA; Padrissa-Altés S; Casillas-Ramirez A; Rodés J; Roselló-Catafau J; Peralta C
Hepatology; 2008 Feb; 47(2):461-72. PubMed ID: 18098300
[TBL] [Abstract][Full Text] [Related]
5. Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation.
Casillas-Ramírez A; Alfany-Fernández I; Massip-Salcedo M; Juan ME; Planas JM; Serafín A; Pallàs M; Rimola A; Rodés J; Peralta C
J Pharmacol Exp Ther; 2011 Jul; 338(1):143-53. PubMed ID: 21487070
[TBL] [Abstract][Full Text] [Related]
6. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion.
Serafín A; Roselló-Catafau J; Prats N; Gelpí E; Rodés J; Peralta C
Hepatology; 2004 Mar; 39(3):688-98. PubMed ID: 14999687
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
Freise H; Palmes D; Spiegel HU
J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin in ischemia-reperfusion injury of the rat lung.
Nowak K; Weih S; Post S; Gebhard MM; Hohenberger P
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):513-22. PubMed ID: 18204165
[TBL] [Abstract][Full Text] [Related]
9. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine 3',5'-monophosphate in rat steatotic liver transplantation.
Jimenez-Castro MB; Casillas-Ramirez A; Massip-Salcedo M; Elias-Miro M; Serafin A; Rimola A; Rodes J; Peralta C
Liver Transpl; 2011 Sep; 17(9):1099-110. PubMed ID: 21671350
[TBL] [Abstract][Full Text] [Related]
12. Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion.
Elias-Miró M; Massip-Salcedo M; Raila J; Schweigert F; Mendes-Braz M; Ramalho F; Jiménez-Castro MB; Casillas-Ramírez A; Bermudo R; Rimola A; Rodes J; Peralta C
Liver Transpl; 2012 Oct; 18(10):1198-208. PubMed ID: 22685091
[TBL] [Abstract][Full Text] [Related]
13. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
Nakano H; Nagasaki H; Barama A; Boudjema K; Jaeck D; Kumada K; Tatsuno M; Baek Y; Kitamura N; Suzuki T; Yamaguchi M
Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
[TBL] [Abstract][Full Text] [Related]
14. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
15. Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers.
Ben Mosbah I; Massip-Salcedo M; Fernández-Monteiro I; Xaus C; Bartrons R; Boillot O; Roselló-Catafau J; Peralta C
Liver Transpl; 2007 Mar; 13(3):410-25. PubMed ID: 17326058
[TBL] [Abstract][Full Text] [Related]
16. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury.
Zaoualí MA; Reiter RJ; Padrissa-Altés S; Boncompagni E; García JJ; Ben Abnennebi H; Freitas I; García-Gil FA; Rosello-Catafau J
J Pineal Res; 2011 Mar; 50(2):213-21. PubMed ID: 21108657
[TBL] [Abstract][Full Text] [Related]
17. Heat shock preconditioning ameliorates liver injury following normothermic ischemia-reperfusion in steatotic rat livers.
Yamagami K; Yamamoto Y; Kume M; Kimoto S; Yamamoto H; Ozaki N; Yamamoto M; Shimahara Y; Toyokuni S; Yamaoka Y
J Surg Res; 1998 Sep; 79(1):47-53. PubMed ID: 9735239
[TBL] [Abstract][Full Text] [Related]
18. The effect of methylprednisolone on warm ischemia-reperfusion injury in the liver.
Saidi RF; Chang J; Verb S; Brooks S; Nalbantoglu I; Adsay V; Jacobs MJ
Am J Surg; 2007 Mar; 193(3):345-7; discussion 347-8. PubMed ID: 17320532
[TBL] [Abstract][Full Text] [Related]
19. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation.
Carrasco-Chaumel E; Roselló-Catafau J; Bartrons R; Franco-Gou R; Xaus C; Casillas A; Gelpí E; Rodés J; Peralta C
J Hepatol; 2005 Dec; 43(6):997-1006. PubMed ID: 16085333
[TBL] [Abstract][Full Text] [Related]
20. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
